Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08879 | 31953865 | Hepatology | Indole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3. | 2020 | Details |
| A08880 | 31953745 | Obes Surg | Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08882 | 31953338 | Appl Environ Microbiol | Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis. | 2020 | Details |
| A08883 | 31953228 | Biochim Biophys Acta Mol Cell Biol Lipids | Effects of peptidoglycan on the development of steatohepatitis. | 2020 | Details |
| A08884 | 31953200 | J Ethnopharmacol | Study on the protection of water extracts of Polygoni Multiflori Radix and Polygoni Multiflori Radix Praeparata against NAFLD and its mechanism. | 2020 | Details |
| A08885 | 31952575 | Adv Clin Chem | Metabolomics in genetic testing. | 2019 | Details |
| A08886 | 31952573 | Adv Clin Chem | Organokines in disease. | 2019 | Details |
| A08888 | 31952262 | Int J Mol Sci | Beneficial Effects of SREBP Decoy Oligodeoxynucleotide in an Animal Model of Hyperlipidemia. | 2020 | Details |
| A08890 | 31950811 | Acta Gastroenterol Belg | Impact of liver inflammation on whole body insulin resistance : a case report on primary biliary cholangitis. | 2020 | Details |
| A08891 | 31950772 | Diabetes Metab J | Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice. | 2019 | Details |
| A08892 | 31950587 | J Dig Dis | Effects and therapeutic mechanism of Yinzhihuang on steatohepatitis in rats induced by a high-fat, high-cholesterol diet. | 2020 | Details |
| A08893 | 31950520 | Hepatology | Nonphagocytic Activation of NOX2 Is Implicated in Progressive Nonalcoholic Steatohepatitis During Aging. | 2020 | Details |
| A08894 | 31949886 | Oxid Med Cell Longev | Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism. | 2019 | Details |
| A08895 | 31949882 | Oxid Med Cell Longev | Renalase Attenuates Mouse Fatty Liver Ischemia/Reperfusion Injury through Mitigating Oxidative Stress and Mitochondrial Damage via Activating SIRT1. | 2019 | Details |
| A08896 | 31949537 | Open Access Maced J Med Sci | The Lifestyle Characteristics in Non-Alcoholic Fatty Liver Disease in the PERSIAN Guilan Cohort Study. | 2019 | Details |
| A08897 | 31949229 | Sci Rep | Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis. | 2020 | Details |
| A08898 | 31949129 | Cell Death Dis | Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress. | 2020 | Details |
| A08899 | 31948298 | Expert Opin Investig Drugs | Targeting the Wnt signaling pathway: the challenge of reducing scarring without affecting repair. | 2020 | Details |
| A08900 | 31948295 | Expert Opin Investig Drugs | Fibroblast growth factor (FGF)-21 based therapies: A magic bullet for nonalcoholic fatty liver disease (NAFLD)? | 2020 | Details |
| A08901 | 31947953 | J Clin Med | Randomised Clinical Trial: Calorie Restriction Regimen with Tomato Juice Supplementation Ameliorates Oxidative Stress and Preserves a Proper Immune Surveillance Modulating Mitochondrial Bioenergetics of T-Lymphocytes in Obese Children Affected by Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A08902 | 31945251 | J Gene Med | Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population. | 2020 | Details |
| A08903 | 31944077 | Pak J Biol Sci | Effect of <i>Rosa canina</i> Distilled Water on Tamoxifen-treated Male Wistar Rats. | 2020 | Details |
| A08904 | 31943701 | Liver Int | Cytolysin-positive Enterococcus faecalis is not increased in patients with non-alcoholic steatohepatitis. | 2020 | Details |
| A08905 | 31943293 | Hepatology | Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study. | 2020 | Details |
| A08906 | 31943268 | Aliment Pharmacol Ther | Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check-up clinic population. | 2020 | Details |
| A08907 | 31942560 | Animal Model Exp Med | A simple method for inducing nonalcoholic steatohepatitis with fibrosis. | 2019 | Details |
| A08908 | 31941974 | Sci Rep | Polycystin 2 is increased in disease to protect against stress-induced cell death. | 2020 | Details |
| A08909 | 31941930 | Sci Rep | Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis. | 2020 | Details |
| A08910 | 31941880 | Med Sci Monit | Electrocardiogram-Based R Wave Pulse Wave Index for Assessment of Carotid Atherosclerosis. | 2020 | Details |
| A08911 | 31941262 | Zhonghua Gan Zang Bing Za Zhi | [Quantitative detection and clinical value of CD44 in patients with nonalcoholic fatty liver disease]. | 2019 | Details |
| A08912 | 31941244 | Zhonghua Gan Zang Bing Za Zhi | [Etiological analysis of hepatopathy of unknown etiology in 470 cases undergoing routine liver biopsy examination]. | 2019 | Details |
| A08913 | 31941015 | Int J Mol Sci | Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. | 2020 | Details |
| A08914 | 31940395 | PLoS One | The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis. | 2020 | Details |
| A08915 | 31940200 | J Med Chem | Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08916 | 31940026 | Biosci Rep | HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels. | 2020 | Details |
| A08917 | 31939706 | Environ Health Perspect | Hepatic Tumor Formation in Adult Mice Developmentally Exposed to Organotin. | 2020 | Details |
| A08918 | 31939698 | AJR Am J Roentgenol | Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08919 | 31937803 | Sci Rep | Integrative analysis of blood and gut microbiota data suggests a non-alcoholic fatty liver disease (NAFLD)-related disorder in French SLAdd minipigs. | 2020 | Details |
| A08921 | 31937252 | BMC Gastroenterol | Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. | 2020 | Details |
| A08922 | 31936903 | Cells | A Review of FoxO1-Regulated Metabolic Diseases and Related Drug Discoveries. | 2020 | Details |
| A08923 | 31936799 | Cells | Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis. | 2020 | Details |
| A08924 | 31936026 | Nutrients | All You Can Feed: Some Comments on Production of Mouse Diets Used in Biomedical Research with Special Emphasis on Non-Alcoholic Fatty Liver Disease Research. | 2020 | Details |
| A08925 | 31935815 | Int J Mol Sci | Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway. | 2020 | Details |
| A08926 | 31935496 | J Ethnopharmacol | A review of Penthorum chinense Pursh for hepatoprotection: Traditional use, phytochemistry, pharmacology, toxicology and clinical trials. | 2020 | Details |
| A08927 | 31935398 | Eur J Pharmacol | Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseases. | 2020 | Details |
| A08928 | 31935149 | Crit Rev Clin Lab Sci | Fructose and hepatic insulin resistance. | 2020 | Details |
| A08930 | 31933238 | Pharmaceut Med | Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date. | 2019 | Details |
| A08931 | 31932588 | Nat Commun | SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis. | 2020 | Details |
| A08932 | 31932016 | Radiologia (Engl Ed) | Quantifying steatosis in the liver and pancreas with MRI in patient with chronic liver disease. | 2020 | Details |
| A08933 | 31931543 | Z Gastroenterol | [What is the (right) target for non-alcoholic fatty liver disease (NAFLD)?] | 2020 | Details |
| A08934 | 31931541 | Z Gastroenterol | A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. | 2020 | Details |
| A08936 | 31930920 | J Med Chem | The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease. | 2020 | Details |
| A08937 | 31930901 | Zhongguo Zhen Jiu | [Mechanism of catgut embedding at back-shu points for nonalcoholic steatohepatitis based on IKK/IKB/NF-κB signaling pathway]. | 2020 | Details |
| A08938 | 31930835 | Pak J Biol Sci | FICK-3 Score Combining Fibrosis-4, Insulin Resistance and Cytokeratin-18 in Predicting Non-alcoholic Steatohepatitis in NAFLD Egyptian Patients. | 2019 | Details |
| A08939 | 31930826 | Pak J Biol Sci | <i>In vitro</i> Anticancer Activity of Quinoa and Safflower Seeds and Their Preventive Effects on Non-alcoholic Fatty Liver. | 2019 | Details |
| A08940 | 31930271 | Food Funct | The preventive effect of phenolic-rich extracts from Chinese sumac fruits against nonalcoholic fatty liver disease in rats induced by a high-fat diet. | 2020 | Details |
| A08941 | 31930115 | Biomed Res Int | Up-Regulated MicroRNA-27b Promotes Adipocyte Differentiation via Induction of Acyl-CoA Thioesterase 2 Expression. | 2019 | Details |
| A08944 | 31929982 | Can J Gastroenterol Hepatol | Association between Hemoglobin Glycation Index and NAFLD in Chinese Nondiabetic Individuals. | 2019 | Details |
| A08945 | 31929840 | Dis Markers | Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals. | 2019 | Details |
| A08946 | 31929156 | J Alzheimers Dis | Staging Alzheimer's Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling. | 2020 | Details |
| A08948 | 31928475 | Expert Opin Investig Drugs | NASH (nonalcoholic steatohepatitis), diabetes, and macrovascular disease: multiple chronic conditions and a potential treatment at the metabolic root. | 2020 | Details |
| A08950 | 31928239 | Expert Rev Gastroenterol Hepatol | Fatty liver in pregnancy: a narrative review of two distinct conditions. | 2020 | Details |
| A08951 | 31928222 | Am J Physiol Gastrointest Liver Physiol | Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver. | 2020 | Details |
| A08952 | 31926994 | Eur J Pharmacol | Challenges and opportunities in drug development for nonalcoholic steatohepatitis. | 2020 | Details |
| A08953 | 31926991 | Eur J Pharmacol | Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway. | 2020 | Details |
| A08954 | 31926984 | J Ethnopharmacol | Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response. | 2020 | Details |
| A08955 | 31926452 | J Nutr Biochem | The nonalcoholic fatty liver disease-like phenotype and lowered serum VLDL are associated with decreased expression and DNA hypermethylation of hepatic ApoB in male offspring of ApoE deficient mothers fed a with Western diet. | 2019 | Details |
| A08957 | 31926204 | Metabolism | Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin α8-mediated activation of RhoA signaling pathway. | 2020 | Details |
| A08958 | 31926095 | J Pediatr Endocrinol Metab | Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity. | 2020 | Details |
| A08959 | 31925474 | Naunyn Schmiedebergs Arch Pharmacol | Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid-a familiar foe. | 2020 | Details |
| A08961 | 31924263 | BMC Res Notes | Association of rs780094 polymorphism of glucokinase regulatory protein with non-alcoholic fatty liver disease. | 2020 | Details |
| A08962 | 31923913 | Pediatr Res | Transmembrane 6 superfamily member 2 167K allele improves renal function in children with obesity. | 2020 | Details |
| A08963 | 31923578 | Diabetes Metab | Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials. | 2020 | Details |
| A08964 | 31923423 | Clin Chim Acta | Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation. | 2020 | Details |
| A08965 | 31922994 | Clin Transl Gastroenterol | A Human REPIN1 Gene Variant: Genetic Risk Factor for the Development of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08966 | 31922976 | Eur J Gastroenterol Hepatol | Noninvasive assessment of liver fibrosis in a real-world cohort of patients with known or suspected chronic liver disease using 2D-shear wave elastography. | 2020 | Details |
| A08967 | 31921938 | Open Forum Infect Dis | Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006-2016. | 2020 | Details |
| A08968 | 31921875 | Front Med (Lausanne) | PNPLA3-A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease. | 2019 | Details |
| A08969 | 31921729 | Front Pediatr | Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A08970 | 31921154 | Front Immunol | Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. | 2019 | Details |
| A08971 | 31920962 | Front Endocrinol (Lausanne) | Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases. | 2019 | Details |
| A08972 | 31920355 | Diabetes Metab Syndr Obes | Salidroside-Mitigated Inflammatory Injury of Hepatocytes with Non-Alcoholic Fatty Liver Disease via Inhibition TRPM2 Ion Channel Activation. | 2019 | Details |
| A08973 | 31919793 | Pharmacoeconomics | Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements. | 2020 | Details |
| A08974 | 31919559 | Arch Toxicol | Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease. | 2020 | Details |
| A08975 | 31919231 | Gut | S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development. | 2020 | Details |
| A08976 | 31918923 | Mol Metab | Deletion of iRhom2 protects against diet-induced obesity by increasing thermogenesis. | 2019 | Details |
| A08977 | 31918130 | Environ Pollut | Targeted metabolomics reveals that 2,3,7,8-tetrachlorodibenzofuran exposure induces hepatic steatosis in male mice. | 2019 | Details |
| A08978 | 31917286 | Exp Mol Pathol | Ataxia telangiectasia mutated pathway disruption affects hepatic DNA and tissue damage in nonalcoholic fatty liver disease. | 2020 | Details |
| A08980 | 31916388 | Mol Nutr Food Res | Differentiated Hepatic Response to Fructose Intake during Adolescence Reveals the Increased Susceptibility to Non-Alcoholic Fatty Liver Disease of Maternal High-Fat Diet Male Rat Offspring. | 2020 | Details |
| A08981 | 31916360 | Liver Int | Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort. | 2020 | Details |
| A08982 | 31915709 | J Diabetes Res | Management of Diabetes Mellitus in Patients with Chronic Liver Diseases. | 2019 | Details |
| A08983 | 31915635 | Prev Nutr Food Sci | Beneficial Effects of Low-Calorie-Carbohydrate/High-Agar Diet on Cardiometabolic Disorders Associated with Non-Alcoholic Fatty Liver Disease in Obese Rats. | 2019 | Details |
| A08984 | 31915606 | J Clin Transl Hepatol | Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A08985 | 31915598 | J Clin Transl Hepatol | Association of GCKR Gene Polymorphisms with the Risk of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease in a Chinese Northern Han Population. | 2019 | Details |
| A08986 | 31915454 | Evid Based Complement Alternat Med | Chinese Herbal Medicine Formula Shenling Baizhu San Ameliorates High-Fat Diet-Induced NAFLD in Rats by Modulating Hepatic MicroRNA Expression Profiles. | 2019 | Details |
| A08987 | 31914720 | Clin Mol Hepatol | Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma. | 2020 | Details |
| A08988 | 31914377 | Cell Metab | Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease. | 2020 | Details |
| A08989 | 31914044 | Medicine (Baltimore) | Urinary fatty acid and retinol binding protein-4 predict CKD progression in severe NAFLD patients with hypertension: 4-year study with clinical and experimental approaches. | 2020 | Details |
| A08990 | 31913753 | J Med Food | Effects of Phytosterol Ester on the Fatty Acid Profiles in Rats with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08991 | 31913745 | Autophagy | SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity. | 2020 | Details |